Drug
Gc301
Gc301: highest development phase Phase 1/2, developed by GeneCradle Inc. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- GeneCradle Inc
Trials
| Drug | Phase | Indication |
|---|---|---|
| GC301 NCT06391736 | Phase 1/2 | Pompe Disease (Late-onset) |
| GC301 NCT05793307 | Phase 1/2 | Pompe Disease Infantile-Onset |
Latest
No recent events.
Follow Gc301 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.